Synthesis of 1,2,3-triazolo-carbanucleoside analogues of ribavirin targeting an HCV in replicon. (Q43047306)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12901908%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Synthesis of 1,2,3-triazolo-carbanucleoside analogues of ribavirin targeting an HCV in replicon (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12901908%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12901908%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Fabien Zoulim

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12901908%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Luigi André Agrofoglio

series ordinal

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12901908%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

5

Raymond F Schinazi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12901908%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Vanessa Escuret

2

1 reference

ORCID Public Data File 2021

author name string

Yoshio Saito

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12901908%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

English

0 references

publication date

1 August 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12901908%20AND%20SRC:MED&resulttype=core&format=json

Bioorganic & Medicinal Chemistry

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12901908%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12901908%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12901908%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

3633-3639

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12901908%20AND%20SRC:MED&resulttype=core&format=json

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900349-3

7 January 2021

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900349-3

7 January 2021

Management of hepatitis C in HIV-infected persons

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900349-3

7 January 2021

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900349-3

7 January 2021

Molecular mechanisms of action of ribavirin

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900349-3

7 January 2021

Hepatitis C virus RNA-dependent RNA polymerase (NS5B) as a mediator of the antiviral activity of ribavirin

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900349-3

7 January 2021

RNA virus error catastrophe: direct molecular test by using ribavirin

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900349-3

7 January 2021

Characterization of soluble hepatitis C virus RNA-dependent RNA polymerase expressed in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900349-3

7 January 2021

Expression of hepatitis C virus NS5B protein: characterization of its RNA polymerase activity and RNA binding

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900349-3

7 January 2021

A recombinant hepatitis C virus RNA-dependent RNA polymerase capable of copying the full-length viral RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900349-3

7 January 2021

RNA-dependent RNA polymerase activity of the soluble recombinant hepatitis C virus NS5B protein truncated at the C-terminal region

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900349-3

7 January 2021

HCV RNA-dependent RNA polymerase as a target for antiviral development

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900349-3

7 January 2021

Structural Analysis of the Hepatitis C Virus RNA Polymerase in Complex with Ribonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900349-3

7 January 2021

Synthesis of carbocyclic nucleosides

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900349-3

7 January 2021

New developments in the enantioselective synthesis of cyclopentyl carbocyclic nucleosides

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900349-3

7 January 2021

Studies on v-triazoles. 7. Antiallergic 9-oxo-1H,9H-benzopyrano[2,3-d]-v-triazoles

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900349-3

7 January 2021

Studies on 1,2,3-triazoles. 13. (Piperazinylalkoxy) [1]benzopyrano[2,3-d]-1,2,3-triazol-9(1H)-ones with combined H1-antihistamine and mast cell stabilizing properties

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900349-3

7 January 2021

1,2,3-Triazole-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D- ribofuranosyl]-3'-spiro-5"-(4"-amino-1",2"-oxathiole 2",2"-dioxide) (TSAO) analogues: synthesis and anti-HIV-1 activity

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900349-3

7 January 2021

Substituent effects on the antibacterial activity of nitrogen-carbon-linked (azolylphenyl)oxazolidinones with expanded activity against the fastidious gram-negative organisms Haemophilus influenzae and Moraxella catarrhalis.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900349-3

7 January 2021

Asymmetric 1,3-Dipolar Cycloaddition Reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900349-3

7 January 2021

Decomposition and addition reactions of organic azides

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900349-3

7 January 2021

Synthesis of carbocyclic phosphononucleosides

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900349-3

7 January 2021

Antiviral activities and cellular toxicities of modified 2',3'-dideoxy-2',3'-didehydrocytidine analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900349-3

7 January 2021

Effect of alpha interferon on the hepatitis C virus replicon

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900349-3

7 January 2021

Effect of combinations of acyclovir with vidarabine or its 5'-monophosphate on herpes simplex viruses in cell culture and in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900349-3

7 January 2021

Delayed treatment with combinations of antiviral drugs in mice infected with herpes simplex virus and application of the median effect method of analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900349-3

7 January 2021

10.1016/S0968-0896(03)00349-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12901908%20AND%20SRC:MED&resulttype=core&format=json

release_qi5sg3gbe5auhfktuhqe3222om

6 November 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qi5sg3gbe5auhfktuhqe3222om

24 November 2022

mapped directly with Wikidata item

1 reference